If this page is too scientific for you go to our home page
Parkinsons is autoimmune disease and treatable please read our e-book. Go to our home page.
CIDPUSA has used a external brain stimulator to help patients with Parkinson plus.
In the more severe cases, the person will become rigid and unable to walk smoothly due to an inability to swing the arms, write legibly, or move the mouth and tongue so as to speak slowly. There will also be increased difficulty in changing from one position to another, or in initiating new movements.
Parkinson's disease affects slightly more men than women at a ratio of three to two. Approximately one in every one hundred persons over age 60 will contract this condition. There is currently no cure for Parkinson's disease. Treatment is towards the physical symptoms as well as helping the person to cope with the problem mentally. This will include emotional support, practical changes in the house to facilitate movement, such as handrails, banisters, regular exercise, and drug therapy.
Predisposing Factors
Carbon monoxide poisoning, high levels of noxious body chemicals, brain infections such as encephalitis, and high doses of certain drugs such as those used to treat schizophrenia.
Signs & Symptoms
The primary symptom of Parkinson's disease is an involuntary tremor, an involuntary shaking of the hands, head, or both. This may be accompanied by a continuous rubbing together of the thumb and forefinger. The tremors are most severe when the affected part of the body is not in use. The tremor is reduced once the body part is moved. There is usually no pain or other sensation but only a decreased ability to move. Depression may result because, while the body is disabled, the mind remains intact.
Frequent falling Excessive salivation
Abdominal cramps Progressive muscle rigidity
Aging Mask-like facial expression no wrinkles
Dysarthria Dysphagia
Completely closed eyelids Decreased blinking frequency
Stooped posture Loss of involuntary gesturing
Senile dementia Familial predisposition
Increased mental dependency Fear
Decreased assertiveness Increased passivity
Indecisiveness
Deterioration in memory or thought processes
Inability or difficulty performing simple tasks
Nutritional Supplements
General Supplement Adult
Choline 100 - 500 mg
CoQ10*
EPO*
Fish oils*
Folic acid 400 - 2,000 mcg
Ginkgo biloba 100 - 160 mg
Inositol 100 - 500 mg
Melatonin*
NADH 2.5 - 5 mg
Tyrosine 500 - 1,000 mg
Vitamin A*
Vitamin B-12 100 - 1,000 mcg
VItamin C*
Vitamin E*
Wheat germ*
Dietary Considerations
With Parkinson's disease, muscle rigidity results in difficulty chewing and eliminating. Therefore the Mechanical Soft Diet is recommended.
Chronic administration of the drug Levodopa may result in vitamin B-6 deficiency, especially in individuals with high requirements for the vitamin due to diabetes, alcoholism or malnutrition. Long-term Levodopa treatment may also increase the individual's need for folacin and vitamin B-12. Supplementation with these vitamin B-Complex vitamins may be necessary.
Administration of levodopa with food is a standard recommendation to reduce problems with nausea and vomiting, however, the presence of protein inhibits drug absorption in two ways: it may delay stomach emptying, thereby providing the gastric mucosa with additional time to inactivate the drug; and high protein meals provide large neutral amino acids (LNAA) which compete with levodopa for blood transport. Thus, there is reduced drug efficacy and a decline in the clinical response. A special diet may be recommended. The most important thing may not be the total amount of protein but the amount consumed at any one meal!
Paradoxically, patients receiving levodopa have significantly lower plasma levels on a reduced protein diet! (Bianchine, 1976)
Excess amounts of manganese accumulate in the liver and central nervous system. Parkinson's disease-like symptoms may result from toxicity due to self-prescribed megadoses.
Homeopathic Remedy
1.* Mercurius Vivus 1M
2.* Stramonium - 15C long term
3. Argentum nitricum tinct. - 30C
4. Agaricus muscarius - 30C
Other remedies, sometimes mentioned include:
Antimonium tartaricum tinct.
Hyoscyamus niger
Kali bromatum
Manganum aceticum
Plumbum metallicum
Tarantula hispanola
Treatment Schedule
Doses cited are to be administered on a 3X daily schedule, unless otherwise indicated. Dose usually continued for 2 weeks. Liquid preparations usually use 8-10 drops per dose. Solid preps are usually 3 pellets per dose. Children use 1/2 dose.
Legend
X = 1 to 10 dilution - weak (triturition)
C = 1 to 100 dilution - weak (potency)
M = 1 to 1 million dilution (very strong)
X or C underlined means it is most useful potency
Asterisk (*) = Primary remedy. Means most necessary remedy. There may be more than one remedy - if so, use all of them.
Herbal Approaches
----------
Herbs
-----------
Ginkgo biloba
Ginseng
Hawthorn
Discussion:
Ginkgo biloba is of notable benefit to brain circulation. Hawthorn may be required to boost the entire circulatory system.
Ginseng may provide a tonic boost.
Several beans (Fava, mucuna pruriens) are noted as having dopamine content.
However, Kava and dopamine are antagonistic, as is Vitex (Agnus Castus). [Jarry, 1994]
In spite of the incidence of depression, St. John's Wort does not seem to be an option. [Muller, 1997]
Constipation and depression are other frequent comorbidities, although some common herbal therapies may interfere with other therapeutic goals.
Care must also be taken to avoid herbs with cholinergic actions, which may affect drug therapy. Herbal ingredients with anticholinergic activity potentiate drug therapy and may increase the risk of side effects; while herbal ingredients, which are cholinergic, may be antagonistic.
Ambrette
Anise
Arnica
Catnip
Chamomile
Comfrey
Cornsilk
Dandelion
Gentian
Ginger
Ginseng
Guar
Hawthorn
Hops
Licorice Root
Lobelia
Maidenhair Fern
Mullein
Peppermint
Psyllium
Red Raspberry Plant
Senega Snakeroot
Shepherd's Purse
Shizandra
Slippery Elm
Sweetflag
Thorn Apple
Anticholinergics may be imperfectly absorbed if: ambrette, catnip, gentian, ginger, guar, hops, maidenhair fern, mullein, peppermint, red raspberry plant, senega snakeroot or slippery elm is being used on a daily basis.
Anise, arnica, chamomile, comfrey, cornsilk, dandelion, ginseng, hawthorn, hops, licorice root, psyllium, shepherd's purse, shizandra and sweetflag contain cholinergic substances.
Thorn apple is anticholinergic.
Hops antagonize the spasmogenic effects of acetylcholine.
The lobeline in lobelia increases acetylcholine response and may therefore potentiate the effects of cholinergic drugs.
Effective treatment of manganese-induced occupational Parkinsonism with p-aminosalicylic acid: a case of 17-year follow-up study.Jiang YM, Mo XA, Du FQ, Fu X, Zhu XY, Gao HY, Xie JL, Liao FL, Pira E, Zheng W.
Department of Occupational Health and Toxicology, Guangxi Medical University, China.
OBJECTIVE: Chronic manganese (Mn) intoxication induces syndromes resembling Parkinson disease. The clinical intervention has largely been unsuccessful. We report a 17-year follow-up study of effective treatment of occupational Mn parkinsonism with sodium para-aminosalicylic acid (PAS). METHODS: The patient, female and aged 50 at the time of treatment, was exposed to airborne Mn for 21 years (1963-1984). The patient had palpitations, hand tremor, lower limb myalgia, hypermyotonia, and a distinct festinating gait. She received 6 g PAS per day through an intravenous drip infusion for 4 days and rested for 3 days as one therapeutic course. Fifteen such courses were carried out between March and June 1987. RESULTS: At the end of PAS treatment, her symptoms were significantly alleviated, and handwriting recovered to normal. Recent follow-up examination at age 67 years (in 2004) showed a general normal presentation in clinical, neurologic, brain magnetic resonance imaging, and handwriting examinations with a minor yet passable gait. CONCLUSIONS: This case study suggests that PAS appears to be an effective drug for treatment of severe chronic Mn poisoning with a promising prognosis.
PMID: 16766929 [PubMed - indexed for MEDLINE]
1: J Neurol Sci. 2002 Jul 15;199(1-2):93-6.
Myoclonic involuntary movement associated with chronic manganese poisoning.Ono K, Komai K, Yamada M.
Department of Neurology and Neurobiology of Aging, Graduate School of Medical Science, Kanazawa University, 13-1 Takara-machi, Kanazawa 920-8640, Japan.
We report a 17-year-old man showing myoclonic involuntary movement (IVM) associated with chronic manganese (Mn) poisoning. The patient, a welder, showed myoclonic IVM mainly in the right upper and lower extremities, elevated levels of Mn in the blood and hair and high-intensity signals in the globus pallidus on T1-weighted MR images. Chelation therapy resulted in improvement of the myoclonic IVM and MRI abnormalities. This is the first report of Mn poisoning characterized by myoclonic IVM without parkinsonism.
PMID: 12084450 [PubMed - indexed for MEDLINE]
Ind Health. 2004 Apr;42(2):111-5.Links
High signal intensities on T1-weighted MRI as a biomarker of exposure to manganese.Kim Y.
Department of Occupational and Environmental Medicine, Ulsan University Hospital, #290-3 Cheonha-Dong, Dong-Ku, Ulsan 682-060, South Korea.
Increased signal in T1-weighted images was observed in the experimental manganese (Mn) poisoning of the non-human primate and a patient with Mn neurointoxication. However, our study showed that the increased signals in magnetic resonance images (MRI) were highly prevalent (41.6%) in Mn-exposed workers. Especially 73.5% of the welders showed increased signal intensities. Blood Mn concentration correlated with pallidal index. These changes in MRI tend to disappear following the withdrawal from the source of Mn accumulation, despite permanent neurological damage. Thus increased signal intensities on a T1-weighted image reflect exposure to Mn, but not necessarily manganism. Our study also showed that the concentration of Mn required to produce increased signal intensities on MRI is much lower than the threshold necessary to result in overt clinical signs of manganism. Increased signal intensities in the globus pallidus were determined by Mn accumulation in the animal experiment. All these results strongly suggest that signal intensities in T1-weighted MRI reflect a target site dose in a biologically-based dose-response model. At which increase of signal intensity, the progression of manganism from Mn exposure occurs, however, remains to be solved.
PMID: 15128159 [PubMed - indexed for MEDLINE]
